History of positron emission tomography (PET) in Poland

• Autorzy: Cegła Paulina , Piotrowski Tomasz

Identyfikatory

DOI

10.1515/bams-2021-0145

• Języki publikacji: EN

Abstrakty

EN

In this short chronological review, we showed the development of positron emission tomography (PET) starting from research on first isotopes through the concepts and prototype of PET machine to the current clinical practice and technological and clinical research. Particular emphasis was placed on a clear description of the milestones of PET development in Poland.

Słowa kluczowe

EN

J-PET; PET/CT; PET/MRI; positron emission tomography

• Wydawca: Uniwersytet Jagielloński - Collegium Medicum ; Index Copernicus Sp. z o.o.
• Czasopismo: Bio-Algorithms and Med-Systems
• Rocznik: 2021
• Tom: Vol. 17, no. 4
• Strony: 259--264
• Opis fizyczny: Bibliogr. 31 poz., rys.

Twórcy

autor

Cegła Paulina

• Department of Nuclear Medicine, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznań, Poland

• https://orcid.org/0000-0002-6676-3436

autor

Piotrowski Tomasz

• Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland
• Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland

Bibliografia

• 1. Teresińska A, Birkenfeld B, Królicki L, Dziuk M. Nuclear medicine training and practice in Poland. Eur J Nucl Med Mol Imag 2014;41: 1995-9.
• 2. Gwardyrs A, Cichon-Bańkowska K. Najważniejsze wydarzenia w historii medycyny nuklearnej. In: Bierkenfeld B, Listewnik M, editors. Medycyna Nuklearna, Obrazowanie molekularne. Wydawnictwo Pomorskiego Uniwersytetu Medycznego w Szczecinie; 2011.
• 3. Lawson R. Przyczynki do historii medycyny nuklearnej, z podkreśleniem roli laureatów Nagród Nobla, NOWOTWORY. J Oncol 2012;62:385-90.
• 4. Chesler DA. Three-dimensional activity distribution from multiple positron scintigraphs. J Nucl Med 1971;12:347-34.
• 5. Jones T, Townsend D. History and future technical innovation in positron emission tomography. J Med Imag (Bellingham) 2017;4: 011013.
• 6. Alavi A, Reivich M, Greenberg J, Hand P, Rosenquist A, Rintelmann W, et al. Mapping of functional activity in brain with 18F-fluorodeoxyglucose. Semin Nucl Med 1981;11:24-31.
• 7. Graban W. Tomografia pozytronowa czyli kuszenie na pustyni. Przegląd Techniczny 1983;30:8-12.
• 8. Królicki L, Teresińska A. Achievements of the Polish PET centers. Nucl Med Rev 2012;15(C Suppl):C1-4.
• 9. Królicki L., Kunikowska J, Mączewska J. Metoda pozytonowej tomografii emisyjnej w medycynie, 2012. Available from: https://instytucja.pan.pl/index.php/aktwydz5/1892-metodapozytonowej-tomografii-emisyjnej-w-medycynie [Accessed 23 Aug 2021].
• 10. NIK. Radiofarmaceutyki. Niecertyfikowane 2019. Available from: https://www.nik.gov.pl/aktualnosci/niecertyfikowaneradiofarmaceutyki.html [Accessed 23 Aug 2021].
• 11. Bedford M, Maisey MN. Requirements for clinical PET: comparisons within Europe. Eur J Nucl Med Mol Imag 2004;31: 208-21.
• 12. Furtak J, Rakowska J, Szylberg T, Harat M, Małkowski B, Harat M. Glioma biopsy based on hybrid dual time-point FET-PET/MRI-a proof of concept study. Front Neurol 2021;11:634609.
• 13. Maksim R, Sierko E, Hempel D, Burzyńska-Śliwowska J, Kidrycka K, Szumowski P, et al. The usefulness of an 18F-FDG-PET/MR examination in a patient with rectal and breast cancer. A case report. Oncol Clin Pract 2019;15:180-4.
• 14. Available from: https://laboratorium.elamed.pl/material.53068 [Accessed 12 Oct 2021].
• 15. Kazakauskaitė E, Žaliaduonytė-Pekšienė D, Rumbinaitė E, Keršulis J, Kulakienė I, Jurkevičius R. Positron emission tomography in the diagnosis and management of coronary artery disease. Medicina (Kaunas) 2018;54:47.
• 16. Cegła P, Ciepłucha A, Pachowicz M, Chrapko B, Piotrowski T, Lesiak M. Nuclear cardiology: an overview of radioisotope techniques used in the diagnosis of cardiovascular disorders. Kardiol Pol 2020;78:520-8.
• 17. Tripathi M, Tripathi M, Damle N, Kushwaha S, Jaimini A, D’Souza MM, et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT. NeuroRadiol J 2014;27:13-21.
• 18. Zhuang H, Codreanu I. Growing applications of FDG PET-CT imaging in non-oncologic conditions. J Biomed Res 2015;29: 189-202.
• 19. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002;32:47-59.
• 20. Alavi A, Zhuang H. Finding infection-help from PET. Lancet 2001; 358:1386.
• 21. Chrapko BE, Chrapko M, Nocuń A, Zubilewicz T, Stefaniak B, Mitura J, et al. Patterns of vascular graft infection in 18F-FDG PET/ CT. Nucl Med Rev 2020;23:63-70.
• 22. Lucignani G, Orunesu E, Cesari M, Marzo K, Pacei M, Bechi G, et al. FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imag 2009; 36:640-7.
• 23. Balink H, Collins J, Bruyn GA, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med 2009;34: 862-8.
• 24. Królicki L, Bruchertseifer F, Kunikowska J, Koziara H, Królicki B, Jakuciński M, et al. Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma. Eur J Nucl Med Mol Imag 2019;46:614-22.
• 25. Kunikowska J, Cieślak B, Gierej B, Patkowski W, Kraj L, Kotulski M, et al. [68Ga]Ga-prostate-specific membrane antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imag 2021;48: 883-92.
• 26. Zakrzewska A. The first digital PET/CT imaging system in Poland. 2020. Available from: https://www.united-imaging.eu/en/news/ the-first-digital-pet-ct-imaging-system-in-poland [Accessed 22 Aug 2021].
• 27. Moskal P, Stępień EŁ. Prospects and clinical perspectives of totalbody PET imaging using plastic scintillators. PET Clin 2020;15: 439-52.
• 28. Moskal P, Kisielewska DY, Shopa R, Bura Z, Chhokar J, Curceanu C, et al. Performance assessment of the 2γ positronium imaging with the total-body PET scanners. EJNMMI Phys 2020;7:44.
• 29. Moskal P, Gajos A, Mohammed M, Chhokar J, Chug N, Curceanu C, et al. Testing CPT symmetry in ortho-positronium decays with positronium annihilation tomography. Nat Commun 2021;12:5658.
• 30. Wawrowicz K, Majkowska-Pilip A, Gaweł D, Chajduk E, Pieńkowski T, Bilewicz A. Au@Pt core-shell nanoparticle bioconjugates for the therapy of HER2+ breast cancer and hepatocellular carcinoma. Model studies on the applicability of 193mPt and 195mPt radionuclides in auger electron therapy. Molecules 2021;26:2051.
• 31. Choiński J, Kilian K, Napiorkowski PJ, Pęgier M, Sentykowska A, Stolarz A, et al. Radiopharmaceuticals production and research center at heavy ion laboratory of University of Warsaw. Acta Phys Pol, A 2021;139:413-6.

Uwagi

Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).